Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Jeffrey C. Thompson"'
Autor:
Jeffrey C. Thompson, Caitlin Tilsed, Christiana Davis, Aasha Gupta, Bihui Melidosian, Chifei Sun, Michael E. Kallen, Cynthia Timmers, Corey J. Langer, Steven M. Albelda
Publikováno v:
Cancers, Vol 16, Iss 16, p 2795 (2024)
Although immune checkpoint blockade (ICB) is currently approved for the treatment of extensive-stage small-cell lung cancer (SCLC) in combination with chemotherapy, relatively few patients have demonstrated durable clinical benefit (DCB) to these the
Externí odkaz:
https://doaj.org/article/6167a08b8cc84d6da79d507f09802e55
Autor:
Apurva Singh, Hannah Horng, Leonid Roshkovan, Joanna K. Weeks, Michelle Hershman, Peter Noël, José Marcio Luna, Eric A. Cohen, Lauren Pantalone, Russell T. Shinohara, Joshua M. Bauml, Jeffrey C. Thompson, Charu Aggarwal, Erica L. Carpenter, Sharyn I. Katz, Despina Kontos
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-12 (2022)
Abstract We aim to determine the feasibility of a novel radiomic biomarker that can integrate with other established clinical prognostic factors to predict progression-free survival (PFS) in patients with non-small cell lung cancer (NSCLC) undergoing
Externí odkaz:
https://doaj.org/article/56ec5c56ca4341e8ac7babf7c546c3c5
Autor:
Bardia Yousefi, Michael J. LaRiviere, Eric A. Cohen, Thomas H. Buckingham, Stephanie S. Yee, Taylor A. Black, Austin L. Chien, Peter Noël, Wei-Ting Hwang, Sharyn I. Katz, Charu Aggarwal, Jeffrey C. Thompson, Erica L. Carpenter, Despina Kontos
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Among non-small cell lung cancer (NSCLC) patients with therapeutically targetable tumor mutations in epidermal growth factor receptor (EGFR), not all patients respond to targeted therapy. Combining circulating-tumor DNA (ctDNA), clinical var
Externí odkaz:
https://doaj.org/article/2bc9f76cb0c2446eb992e36476f5b7bf
Autor:
Moen Sen, Ryan M. Hausler, Keely Dulmage, Taylor A. Black, William Murphy, Charles H. Pletcher Jr, Ling Wang, Chang Chen, Stephanie S. Yee, Scott J. Bornheimer, Kara N. Maxwell, Ben Z. Stanger, Jonni S. Moore, Jeffrey C. Thompson, Erica L. Carpenter
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 7, Pp n/a-n/a (2022)
Externí odkaz:
https://doaj.org/article/0a106db67e8d471ba41b7ba01eec8319
Autor:
Jeffrey C. Thompson, MD, MTR, Charu Aggarwal, MD, MPH, Janeline Wong, BS, Vivek Nimgaonkar, BS, Wei-Ting Hwang, PhD, Michelle Andronov, BS, David M. Dibardino, MD, Christoph T. Hutchinson, MD, MA, Kevin C. Ma, MD, Anthony Lanfranco, MD, MS, Edmund Moon, MD, Andrew R. Haas, MD, PhD, Aditi P. Singh, MD, Christine A. Ciunci, MD, MSCE, Melina Marmarelis, MD, MSCE, Christopher D’Avella, MD, Justine V. Cohen, DO, Joshua M. Bauml, MD, Roger B. Cohen, MD, Corey J. Langer, MD, Anil Vachani, MD, MSCE, Erica L. Carpenter, MBA, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 4, Pp 100301- (2022)
Introduction: The availability of targeted therapies has transformed the management of advanced NSCLC; however, most patients do not undergo guideline-recommended tumor genotyping. The impact of plasma-based next-generation sequencing (NGS) performed
Externí odkaz:
https://doaj.org/article/1e4a79ab12aa4b34955ec3972d774b0c
Autor:
Vivek Nimgaonkar, Jeffrey C. Thompson, Lauren Pantalone, Tessa Cook, Despina Kontos, Anne Marie McCarthy, Erica L. Carpenter
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
We investigated racial disparities in a 30-day composite outcome of readmission and death among patients admitted across a 5-hospital health system following an index COVID-19 admission. A dataset of 1,174 patients admitted between March 1, 2020 and
Externí odkaz:
https://doaj.org/article/d32439e29e054ea598553a2e6cc0921f
Autor:
Michelle Hershman, Bardia Yousefi, Lacey Serletti, Maya Galperin-Aizenberg, Leonid Roshkovan, José Marcio Luna, Jeffrey C. Thompson, Charu Aggarwal, Erica L. Carpenter, Despina Kontos, Sharyn I. Katz
Publikováno v:
Cancers, Vol 13, Iss 23, p 5985 (2021)
This study tackles interobserver variability with respect to specialty training in manual segmentation of non-small cell lung cancer (NSCLC). Four readers included for segmentation are: a data scientist (BY), a medical student (LS), a radiology train
Externí odkaz:
https://doaj.org/article/1230c50e1ea44d689db461a29315b8c6
Autor:
Astero Klampatsa, Shaun M. O’Brien, Jeffrey C. Thompson, Abhishek S. Rao, Jason E. Stadanlick, Marina C. Martinez, Maria Liousia, Edward Cantu, Keith Cengel, Edmund K. Moon, Sunil Singhal, Evgeniy B. Eruslanov, Steven M. Albelda
Publikováno v:
OncoImmunology, Vol 8, Iss 9 (2019)
Given the growing interest and promising preliminary results of immunotherapy in malignant pleural mesothelioma (MPM), it has become important to more fully understand the immune landscape in this tumor. This may be especially relevant in deciding wh
Externí odkaz:
https://doaj.org/article/278924de4ef344fba6aca323b62dccba
Autor:
Jeffrey C. Thompson, Anil Vachani
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 207:1120-1122
Autor:
Apurva Singh, Hannah Horng, Leonid Roshkovan, Sharyn I. Katz, Despina Kontos, Jeffrey C. Thompson
Publikováno v:
Medical Imaging 2023: Computer-Aided Diagnosis.